Pharmacological interventions versus no pharmacological intervention for ischaemia reperfusion injury in liver resection surgery performed under vascular control

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Abu Amara, Mahmoud ^a   Gurusamy, Kurinchi Selvan ^a   Hori, Satoshi ^b   Glantzounis, George ^c   Fuller, Barry ^a   Davidson, Brian R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Anti inflammatory agents; Elective; Fibrinolytic agents therapeutic use ; Hepatectomy *methods ; Humans; Liver *blood supply ; Non steroidal therapeutic use ; Randomized controlled trials as topic; Reperfusion injury *prevention control ; Surgical procedures; Vasodilator agents therapeutic use

Indexed keywords

ALLOPURINOL; ALPHA TOCOPHEROL; AMRINONE; ANTIOXIDANT; GLUCOSE; MANNITOL; METHYLPREDNISOLONE; MULTIVITAMIN; OZAGREL; PENTOXIFYLLINE; PROSTAGLANDIN E1; TRIMETAZIDINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; LENGTH OF STAY; LIVER FAILURE; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; LIVER RESECTION; MORBIDITY; MORTALITY; POSTOPERATIVE COMPLICATION; REPERFUSION INJURY; REVIEW;

EID: 77950178324     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007472.pub2     Document Type: Review

References (116)

1. Aldrighetti 2006 {published data only} * Aldrighetti L, Pulitano C, Arru M, Finazzi R, Catena M, Soldini L, et al.Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: A prospective randomized study. Liver Transplantation 2006;12(6):941-9.
2. Finnazi R, Pulitano C, Aldrighetti L, Arru M, Catena M, Milani F, et al.Benefit of preoperative corticosteroid therapy on the hepatic ischaemia-reperfusion injury and cytokine response in patients undergoing hepatic resection: a prospective randomized trial. Journal of Hepatolology 2005;42(Suppl 2):49.
3. Pulitano C, Aldrighetti L, Arru M, Finazzi R, Catena M, Guzzetti E, et al.Preoperative methylprednisolone administration maintains coagulation homeostasis in patients undergoing liver resection: importance of inflammatory cytokine modulation. Shock 2007;28:401-5.
4. Pulitanò C, Aldrighetti L, Arru M, Finazzi R, Soldini L, Catena M, et al.Prospective randomized study of the benefits of preoperative corticosteroid administration on hepatic ischemia-reperfusion injury and cytokine response in patients undergoing hepatic resection. HPB 2007;9(3):183-9.
5. Pulitanò C, Aldrighetti L, Finazzi R, Arru M, Catena M, Ferla G. Inihibition of cytokine response by methylprednisolone attenuates antithrombin reduction following hepatic resection. Thrombosis and Haemostasis 2005;93(6):1199-200.
6. Bartels 2004 {published data only} Bartels M, Biesatski HK, Engelhart K, Sendlhofer G, Rehak P, Nagel E. Pilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: a double blind, randomized, placebo-controlled trial. Clinical Nutrition 2004;23(6):1360-70.
7. Cerwenka 1998 {published data only} Cerwenka H, Bacher H, Werkgartner G, El-Shabrawi A, Quehenberger F, Hauser H, et al.Antioxidant treatment during liver resection for alleviation of ischemia-reperfusion injury. Hepato-Gastroenterology 1998;45(21):777-82.
8. Cerwenka 1999 {published data only} Cerwenka H, Khoschsorur G, Bacher H, Werkgartner G, El-Shabrawi A, Quehenberger F, et al.Normothermic liver ischemia and antioxidant treatment during hepatic resections. Free Radical Research 1999;30(6):463-9.
9. Kawano 2005 {published data only} Kawano T, Hosokawa N, Maruta T, Maruta N, Takasaki M. Reevaluation of protective effects of alprostadil on hepatic function in patients undergoing hepatectomy. Masui. The Japanese Journal of Anesthesiology 2005;54(9):982-91.
10. Kostopanagiotou 2006 {published data only} Kostopanagiotou G, Pandazi AK, Andreadou I, Markantonis SL, Niokou D, Teloudis A, et al.Effects of mannitol in the prevention of lipid peroxidation during liver resection with hepatic vascular exclusion. Journal of Clinical Anesthesia 2006;18(8):570-4.
11. Muratore 2003 {published data only} Muratore A, Ribero D, Ferrero A, Bergero R, Capussotti L. Prospective randomized study of steroids in the prevention of ischaemic injury during hepatic resection with pedicle clamping. The British Journal of Surgery 2003;90(1):17-22.
12. Orii 2000 {published data only} Orii R, Sugawara Y, Hayashida M, Yamada Y, Chang K, Takayama T, et al.Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: A comparative study with prostaglandin E1. British Journal of Anaesthesia 2000;85(3):389-95.
13. Settaf 2001 {published data only} Settaf A, Zaim N, Bellouch M, Tillement JP, Morin D. Trimetazidine alleviates ischemia-reperfusion injury induced by vascular clamping of the liver. Therapie 2001;56(5):569-74.
14. Shirabe 1996 {published data only} Shirabe K, Takenaka K, Yamamoto K, Kitamura M, Itasaka H, Matsumata T, et al.The role of prostanoid in hepatic damage during hepatectomy. Hepato-Gastroenterology 1996;43(9):596-601.
15. Stadheim 2000 {published data only} Stadheim LM, Gores GJ, Lee TC, Nagorney DM. Normothermic ischemia-reperfusion injury during hepatic resection: A prospective randomized placebo controlled study of pretreatment with misoprostol or pentoxifylline. Hepatology 2000;32(4):250A.
16. Sugawara 1998 {published data only} Sugawara Y, Kubota K, Ogura T, Esumi H, Inoue K, Takayama T, et al.Protective effect of prostaglandin E1 against ischemia/reperfusion-induced liver injury: results of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy. Journal of Hepatology 1998;29(6):969-76.
17. Tang 2007 {published data only} * Tang L, Tian F, Tao W, Cui J. Hepatocellular glycogen in alleviation of liver ischemia-reperfusion injury during partial hepatectomy. World Journal of Surgery 2007;31(10):2039-43.
18. Tang LJ, Tian FZ, Gao XM. Hepatocellular glycogen in alleviation of liver ischemia reperfusion injury. Hepatobiliary & Pancreatic Diseases International 2002;1(4):532-5.
19. Vriens 2002 {published data only} Vriens MR, Marinelli A, Harinck HIJ, Zwinderman KH, van de Velde CJH. The role of allopurinol in human liver ischemia/ reperfusion injury: A prospective randomized clinical trial. Hepato-Gastroenterology 2002;49(46):1069-73.
20. Yamashita 2001 {published data only} Yamashita Y, Shimada M, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, et al.Effects of preoperative steroid administration on surgical stress in hepatic resection - Prospective randomised trial. Archives of Surgery 2001;136(3):328-33.
21. Baek 1999 {published data only} Baek Y, Nakano H, Kumada K, Nagasaki H, Kigawa G, Sasaki J, et al.Administration of prostaglandin E1 reduces post-operative hepatocellular damage and restores hepatic integrity in patients undergoing hepatectomy. Hepato-Gastroenterology 1999;46(27):1836-41.
22. Beck-Shimmer 2008 {published data only} Beck-Shimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, et al.A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Annals of Surgery 2008;248:909-18.
23. Dunschede 2006 {published data only} Dunschede F, Erbes K, Kircher A,Westermann S, Seifert J, Schad A, et al.Reduction of ischemia reperfusion injury after liver resection and hepatic inflow occlusion by (alpha)-lipoic acid in humans. World Journal of Gastroenterology 2006;12(42):6812-7.
24. Garcia 1994 {published data only} Garcia-Valdecasas JC, Rull R, Rimola A, Grande L, Beltran J, Angas J, et al.The role of systemic prostaglandins during human liver transplantation. Annals of the New York Academy of Sciences 1994;723:473-5.
25. Hanazaki 2000 {published data only} Hanazaki K, Kajikawa S, Fujimori Y, Nakata S, Shimozawa N, Koide N, et al.Effects of prostaglandin E1 administration during hepatectomy for cirrhotic hepatocellular carcinoma. Hepato-Gastroenterology 2000;47(32):461-4.
26. Hassanain 2008 {published data only} Hassanain M, Schricker T, Metrakos P, Carvalho G, Vrochides D, Lettermann R. Hepatic protection by perioperative metabolic support?. Nutrition 2008;24:1217-9.
27. Hayakawa 1994 {published data only} Hayakawa J, Yoshida G, Usuda Y. Effect of prostaglandin E1 on arterial ketone body ratio in hepatectomy. Journal of Anesthesia 1994;8(2):167-71.
28. Inagaki 1999 {published data only} Inagaki H, Nonami T, Kurokawa T, Takeuchi Y, Okuda N, Nakao A, et al.Effects of nafamostat mesilate, a synthetic protease inhibitor, on immunity and coagulation after hepatic resection. Hepato-Gastroenterology 1999;46(30):3223-8.
29. Inagaki Kurokaw 1999 {published data only} Inagaki H, Kurokawa T, Nonami T, Miwa T, Nakao A, Takagi H. The effect of intraportal administration of prostaglandin E1 on liver blood flow and liver function. Hepato-Gastroenterology 1999; 46(29):2909-13.
30. Kaiho 2008 {published data only} Kaiho T, Tsuchiya S, Yanagisawa S, Takeuchi O, Togawa A, Okamoto R, et al.Effect of the herbal medicine Inchin-Ko-To for serum bilirubin in hepatectomized patients. Hepato-Gastroenterology 2008;55:150-4.
31. Katsuramaki 1996 {published data only} Katsuramaki T, Mukaiya M, Yamashiro K, Kimura H, Denno R, Hirata K. Beneficial effects of administering intraportal prostaglandin E1 postoperatively to hepatectomy patients with massive intraoperative blood loss. Surgery Today 1996;26:895-9.
32. Kim 2002 {published data only} Kim YI, Hwang YJ, Song KE, Yun YK, Lee JW, Chun BY. Hepatocyte protection by a protease inhibitor against ischemia/ reperfusion injury of human liver. Journal of the American College of Surgeons 2002;195(1):41-50.
33. Kim 2006 {published data only} Kim YI, Chung HJ, Song KE, Hwang YJ, Lee JW, Lee YJ, et al.Evaluation of a protease inhibitor in the prevention of ischemia and reperfusion injury in hepatectomy under intermittent Pringle maneuver. American Journal of Surgery 2006;191(1):72-6.
34. Kim 2007 {published data only} Kim YI, Fujita S, Hwang YJ, Chun JM, Song KE, Chun BY. Successful intermittent application of the Pringle maneuver for 30 minutes during human hepatectomy: a clinical randomized study with use of a protease inhibitor. Hepato-Gastroenterology 2007;54:2055-60.
35. Li 2004 {published data only} Li SQ, Liang LJ. [Protection of liver function with protease inhibitor from ischemia-reperfusion injury in hepatocellular carcinoma patients undergoing hepatectomy after hepatic inflow occlusion]. Chinese Journal of Bases and Clinics in General Surgery 2004;11(1):61-4.
36. Marx 2000 {published data only} Holtje M, Mahr KH, Bornscheuer A, Marx G, Stamme C, Rueckoldt H, et al.[Circulatory function and oxygenation during hemihepatectomy. Dopamine versus dopexamine]. Der Anaesthesist 1999;48(4):224-30.
37. * Marx G, Leuwer M, Holtje M, Bornscheuer A, Herrmann H, Mahr KH, et al.Low-dose dopexamine in patients undergoing hemihepatectomy: an evaluation of effects on reduction of hepatic dysfunction and ischaemic liver injury. Acta Anaesthesiologica Scandinavica 2000;44(4):410-6.
38. Nakagawa 1991 {published data only} Nakagawa I, Izumi H, Fujii K, Kurokawa H, Kusunoki S, Yuge O. Comparison of the effect of PGE1 and dopamine on arterial blood ketone body ratio in hepatectomized patients. Hiroshima Journal of Anesthesia 1991;27(4):367-71.
39. Nakayama 1995 {published data only} Nakayama M, Kanaya N, Fujita S, Kawana S, Namiki A. [Effect of prostaglandin E1 on arterial ketone body ratio during and after hepatectomy]. Masui. The Japanese Journal of Anesthesiology 1995;44(9):1224-7.
40. Schemmer 2008 {published data only} Schemmer P, Nickkholgh A, Schneider H, Sobirey M, Weigand M, Koch M, et al.PORTAL: Pilot study on the safety and tolerance of preoperative melatonin application in patients undergoing major liver resection: A double-blind randomized placebo-controlled trial. BMC Surgery 2008;8:2.
41. Schmidt 2007 {published data only} Schmidt SC, Hamann S, Langrehr JM, Hoflich C, Mittler J, Jacob D, et al.Preoperative high-dose steroid administration attenuates the surgical stress response following liver resection: results of a prospective randomized study. Journal of Hepato-Biliary-Pancreatic Surgery 2007;14:484-92.
42. Sheth 2005 {published data only} * Sheth H, Glantzounis G, Hafez T, Quaglia A, Duncan J, Davidson BR. A randomised double-blind controlled clinical trial to assess the effects of prophylactic N-acetylcysteine on liver injury during liver resection. The British Journal of Surgery 2005;92(10):1307.
43. Sheth H, Glantzounis G, Hafez T, Quaglia A, Duncan J, Davidson BR. Does perioperative N-aceylcysteine prevent ischaemia reperfusion injury during liver resection?: A prospectively randomised double blind clinical trial. Gut 2005;54:A39.
44. Shimada 1994 {published data only} Shimada M, Matsumata T, Taketomi A, Shirabe K, Yamamoto K, Sugimachi K. The role prostaglandins in hepatic resection. Prostaglandins Leukotrienes and Essential Fatty Acids 1994;50(2):65-8.
45. Shimada 1996 {published data only} Shimada M, Saitoh A, Kano T, Takenaka K, Sugimachi K. The effect of a perioperative steroid pulse on surgical stress in hepatic resection. International Surgery 1996;81(1):49-51.
46. Suehiro 2008 {published data only} Suehiro T, Shimura T, Okamura K, Okada T, Okada K, Hashimoto S, et al.The effect of hyperbaric oxygen treatment on postoperative morbidity of left lobe donor in living donor adult liver transplantation. Hepato-Gastroenterology 2008;55:1014-9.
47. Une 1995 {published data only} Une Y, Shimamura T, Uchino J. Effect of prostaglandin E(1) on hepatic function after hepatectomy in patients with chronic liver disease. Clinical Therapeutics 1995;17(6):1118-25.
48. Wada 1995 {published data only} Wada Y, Zaima M, Mori K, Egawa H, Higashiyama H, Iwata S, et al.Effect of gabexate mesilate on thrombin and plasmin generation after hepatic resection in cirrhotic patients. European Surgical Research 1995;27(1):57-62.
49. Abu-Amara 2009a Abu-Amara M, Gurusamy KS, Davidson BR. Pharmacological interventions to reduce ischaemia-reperfusion injury for liver resections performed under vascular control. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD007472]
50. Abu-Amara 2009b Abu-Amara M, Gurusamy KS, Glantzounis G, Fuller B, Davidson BR. Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular control. Cochrane Database of Systematic Reviews 2009, Issue 4.[Art. No.: CD008154. DOI: 10.1002/14651858.CD008154]
51. Azoulay 2005 Azoulay D, Eshkenazy R, Andreani P, Castaing D, Adam R, Ichai P, et al.In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Annals of Surgery 2005;241(2):277-85.
52. Azoulay 2006 Azoulay D, Lucidi V, Andreani P, Maggi U, Sebagh M, Ichai P, et al.Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. Journal of the American College of Surgeons 2006;202(2): 203-11.
53. Belghiti 1993 Belghiti J, Kabbej M, Sauvanet A, Vilgrain V, Panis Y, Fekete F. Drainage after elective hepatic resection. A randomized trial. Annals of Surgery 1993;218(6):748-53.
54. Birlouez-Aragon 2003 Birlouez-Aragon I, Tessier FJ. Antioxidant vitamins and degenerative pathologies. A review of vitamin C. The Jornal of Nutrition, Health and Aging 2003;7:103-9.
55. Bjelakovic 2009 Bjelakovic G, Gluud LL, Nikolova D, Bjelakovic M, Gluud C. Antioxidant supplements for liver disease. Journal of Hepatology 2009;50(Suppl. No 1):S356.
56. BNF53 2007 Martin J, Jordan B, Macfarlane CR, Ryan R, Wagle S, et al.British National Formulary. 53. London: BMJ and RPS, March 2007. [: ISBN: 978 085369 731 2]
57. Chamorro 2004 Chamorro A, Planas AM, Muner DS, Deulofeu R. Uric acid administration for neuroprotection in patients with acute brain ischemia. Medical Hypotheses 2004;62:173-6.
58. Chouker 2005 Chouker A, Martignoni A, Schauer R, Dugas M, Rau HG, Jauch KW, et al.Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils. Archives of Surgery 2005;140(2):129-36.
59. Couinaud 1999 Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Digestive Surgery 1999;16(6):459-67.
60. Cressman 1996 Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al.Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274(5291):1379-83.
61. DeMets 1987 DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50.
62. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
63. Egger 1997 Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34.
64. El-Ghoneimi 2007 El-Ghoneimi A, Cursio R, Schmid-Alliana A, Tovey M, Lasfar A, Michiels JF, et al.Pentoxifylline inhibits liver expression of tumour necrosis factor alpha mRNA following normothermic ischemia-reperfusion. HPB 2007;9:112-9.
65. Engelhart 1998 Engelhart K, Jentzsch AM, Furst P, Biesalski HK. Short-term parenteral application of a-tocopherol leads to increased concentration in plasma and tissue of the rat. Free Radical Research 1998;29:421-6.
66. Galaris 2006 Galaris D, Barbouti A, Korantzopoulos P. Oxidative stress in hepatic ischemia-reperfusion injury: the role of antioxidants and iron chelating compounds. Current Pharmaceutical Design 2006;12(23): 2875-90.
67. Georgiev 2006 Georgiev P, Dahm F, Graf R, Clavien PA. Blocking the path to death: anti-apoptotic molecules in ischemia / reperfusion injury of the liver. Current Pharmaceutical Design 2006;12(23):2911-21.
68. Glanemann 2004 Glanemann M, Strenziok R, Kuntze R, Münchow S, Dikopoulos N, Lippek F, et al.Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/ reperfusion injury. Surgery 2004;135(2):203-14.
69. Glantzounis 2005 Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transplantation 2005;11(9):1031-47.
70. Gluud 2009 Gluud C, Nikolova D, Klingenberg SL, Alexakis N, Als-Nielsen B, D'Amico G, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2009, Issue 3. Art. No.: LIVER.
71. Goenen 1985 Goenen M, Pedemonte O, Baele P, Col J. Amrinone in the management of low cardiac output after open heart surgery. American Journal of Cardiology 1985;56:33B-38B.
72. Gurusamy 2009a Gurusamy KS, Sheth H, Kumar Y, Sharma D, Davidson BR. Methods of vascular occlusion for elective liver resections. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858. CD007632]
73. Gurusamy 2009b Gurusamy KS, Kumar Y, Ramamoorthy R, Sharma D, Davidson BR. Vascular occlusion for elective liver resections. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858. CD007530]
74. Gurusamy 2009c Gurusamy KS, Kumar Y, Pamecha V, Sharma D, Davidson BR. Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD007629]
75. Gurusamy 2009d Gurusamy KS, Gluud C, Nikolova D, Davidson BR. Assessment of risk of bias in randomized clinical trials in surgery. The British Journal of Surgery 2009;96(4):342-9. [PUBMED: 19283747]
76. HES 2005 Hospital Episode Statistics. Main operations. 3 character: 2004-05. http://www.hesonline.nhs.uk/Ease/servlet/ContentServer? siteID=1937&categoryID=205 (accessed 17 April 2007).
77. Hide 1995 Hide EJ, Ney P, Piper J, Thiemermann C, Vane JR. Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. British Journal of Pharmacology 1995;116:2435-40.
78. Higgins 2002 Higgins JPT, Thompson SG. Quantifying heterogeneity in a metaanalysis. Statistics in Medicine 2002;21(11):1539-58.
79. Higgins 2008 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration 2008.
80. Ibrahim 2006 Ibrahim S, Chen CL, Lin CC, Yang CH, Wang CC, Wang SH, et al.Intraoperative blood loss is a risk factor for complications in donors after living donor hepatectomy. Liver Transplantation 2006;12(6):950-7.
81. Jeon 2001 Jeon BR, Yeom DH, Lee SM. Protective effect of allopurinol on hepatic energy metabolism in ischemic and reperfused rat liver. Shock 2001;15:112-7.
82. Kim 1996 Kim YI, Hiratsuka K, Kitano S, Joo DH, Kamada N, Sugimachi K. Simple in situ hypothermia reduced ischaemic injury to human liver during hepatectomy. European Journal of Surgery 1996;162(9):717- 21.
83. Kjaergard 2001 Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
84. Koti 2003 Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Digestive Surgery 2003;20(5):383-96.
85. Kupiec 2005 Kupiec-Weglinski JW, Busuttil RW. Ischemia and reperfusion injury in liver transplantation. Transplantation Proceedings 2005;37(4):1653-6.
86. Larsen 2002 Larsen M, Webb G, Kennington S, Kelleher N, Sheppard J, Kuo J. Mannitol in cardioplegia as an oxygen free radical scavenger measured by malondialdehyde. Perfusion 2002;17:51-5.
87. Lopasch 2003 Lopasch GD,Marzilli M.Mode of action of trimetazidine and other new metabolic agents in the treatment of ischemic heart disease. Seminars in Cardiothoracic and Vascular Anesthesia 2003;7:91-6.
88. Macaskill 2001 Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Statistics in Medicine 2001;20(4):641-54.
89. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
90. Moher 2001 Moher D, Schulz KF, Altman DG (for the CONSORT Group). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357(9263) :1191-4.
91. Murrell 1986 Murrell GA, Rapeport WG. Clinical pharmacokinetics of allopurinol. Clinical Pharmacokinetics 1986;11(5):343-53.
92. Nathens 2002 Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, et al.Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Annals of Surgery 2002;236(6):814-22.
93. Newell 1992 Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology 1992;21(5):837-41.
94. Rabl 1995 Rabl H, Khoschsonrr G, Petek W. Antioxidative vitamin treatment: effect of lipid peroxidation and limb swelling after revascularisation operations. World Journal of Surgery 1995;19:738-44.
95. RevMan 2008 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
96. Royle 2003 Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
97. Rüdiger 2002 Rüdiger HA, Clavien PA. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 2002;122(1):202-10.
98. Saidi 2007 Saidi RF, Chang J, Verb S, Brooks S, Nalbantoglu I, Adsay V, et al.The effect of methylprednisolone on warm ischemia-reperfusion injury in the liver. American Journal of Surgery 2007;193(3):345- 7; discussion 347-8.
99. Schror 1988 Schror K, Thiemermann C, Ney P. Protection of the ischemic myocardium from reperfusion injury by prostaglandin E1 inhibition of ischemia-induced neutrophil activation. Naunyn-Schmiedeberg's Archives of Pharmacology 1988;338(3):268-74.
100. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408- 12.
101. Selzner 2007 Selzner M, Selzner N, Jochum W, Graf R, Clavien PA. Increased ischemic injury in old mouse liver: an ATP-dependent mechanism. Liver Transplantation 2007;13:382-90.
102. Seo 2002 Seo MY, Lee SM. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats. Journal of Hepatology 2002;36:72-7.
103. Shimada 1998 Shimada M, Takenaka K, Fujiwara Y, Gion T, Shirabe K, Yanaga K, et al.Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. The British Journal of Surgery 1998;85(2):195-8.
104. Smyrniotis 2006 Smyrniotis V, Theodoraki K, Arkadopoulos N, Fragulidis G, Condi-Pafiti A, Plemenou-Fragou M, et al.Ischemic preconditioning versus intermittent vascular occlusion in liver resections performed under selective vascular exclusion: a prospective randomized study. American Journal of Surgery 2006;192(5):669-74.
105. Soltys 2001 Soltys K, Dikdan G, Koneru B. Oxidative stress in fatty livers of obese Zucker rats: Rapid amelioration and improved tolerance to warm ischemia with tocopherol. Hepatology 2001;34:13-8.
106. Staubbs 1975 Staubbs SS. Corticosteroids and bioavailability. Transplantation Proceedings 1975;7:11-9.
107. Strasberg 2000 Strasberg SM, Belghiti J, Clavien PA, Gadzijev E, Garden JO, Lau WY, et al.The Brisbane 2000 terminology of liver anatomy and resections. HPB Surgery 2000;2(3):333-9.
108. Sweeting 2004 Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Statistics in Medicine 2004;23(9):1351-75.
109. Traber 1994 Traber MG. Determinants of plasma vitamin E concentrations. Free Radical Biology and Medicine 1994;16:229-39.
110. Tsimoyiannis 1993 Tsimoyiannis EC, Moutesidou KJ, Moschos CM, Karayianni M, Karkabounas S, Kotoulas OB. Trimetazidine for prevention of hepatic injury induced by ischaemia and reperfusion in rats. European Journal of Surgery 1993;159:89-93.
111. Wang 2001 Wang M, SakonM, Umeshita K, Okuyama M, Shiozaki K, Nagano H, et al.Prednisolone suppresses ischemia-reperfusion injury of the rat liver by reducing cytokine production and calpain mu activation. Journal of Hepatology 2001;34(2):278-83.
112. Webel 1974 Webel ML, Ritts RE, Taswell HF, Danadio JV, Woods JE. Cellular Immunity after intravenous administration of methylprednisolone. Journal of Laboratory and Clinical Medicine 1974;83:383-92.
113. Weinbroum 2006 Weinbroum AA. Concomitant administration of mannitol and N-acetylcysteine for the prevention of lung reperfusion injury. The Journal of Trauma 2006;60:1290-6.
114. Wood 2008 Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al.Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.) 2008;336:601-5.
115. Yamamoto 1999 Yamamoto T, Habuchi Y, Tanaka H, Suto F, Morikawa J, Kashima K, et al.EP receptor-mediated inhibition by prostaglandin E(1) of cardiac L-type Ca(2+) current of rabbits. American Journal of Physiology 1999;277:H1369-H1374.
116. Yoshimura 2004 Yoshimura Y, Kubo S, Shirata K, Hirohashi K, Tanaka H, Shuto T, et al.Risk factors for postoperative delirium after liver resection for hepatocellular carcinoma. World Journal of Surgery 2004;28(10):982-6.